Effects of sub-50 oral contraceptives on homocysteine metabolism: a preliminary study. 1992

R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
Department of Obstetrics/Gynecology, University Hospital Nijmegen, The Netherlands.

The influence of a monophasic sub-50 oral contraceptive (OC), Marvelon, on fasting total homocysteine levels was investigated in OC users and controls. Homocysteine levels in serum of OC users were significantly higher (P less than .01) than in controls during the low-hormonal phase of the cycles and comparable with levels determined in heterozygotes for homocystinuria. Blood levels of pyridoxal phosphate (PLP) were significantly lower (P less than .05) in OC users both in the low and high hormonal phase. However, there were no significant differences in the levels of homocysteine nor in folate and vitamin B12 between both groups in the high-hormonal phase. In contrast to the control group, the homocysteine levels in OC users in the high-hormonal phase of the cycle were significantly decreased compared with those on a low-hormonal day (P less than .05). These data suggest that cyclically recurrent periods of hyperhomocysteinemia do occur during sub-50 OC use in normal women and might be considered a predisposition to the occurrence of vascular complications.

UI MeSH Term Description Entries
D009652 Norpregnenes Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
D011732 Pyridoxal Phosphate This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE). Pyridoxal 5-Phosphate,Pyridoxal-P,Phosphate, Pyridoxal,Pyridoxal 5 Phosphate,Pyridoxal P
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006710 Homocysteine A thiol-containing amino acid formed by a demethylation of METHIONINE. 2-amino-4-mercaptobutyric acid,Homocysteine, L-Isomer,2 amino 4 mercaptobutyric acid,Homocysteine, L Isomer,L-Isomer Homocysteine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014805 Vitamin B 12 A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12. Cobalamin,Cyanocobalamin,Cobalamins,Eritron,Vitamin B12,B 12, Vitamin,B12, Vitamin

Related Publications

R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
January 1993, Gynecologic and obstetric investigation,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
September 2002, Metabolism: clinical and experimental,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
April 2006, Contraception,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
October 1970, Diabetologia,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
June 1986, The Journal of reproductive medicine,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
January 1976, Advances in clinical chemistry,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
October 1990, American journal of obstetrics and gynecology,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
September 1986, The Journal of reproductive medicine,
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
October 1969, Lancet (London, England),
R P Steegers-Theunissen, and G H Boers, and E A Steegers, and F J Trijbels, and C M Thomas, and T K Eskes
October 1966, Lancet (London, England),
Copied contents to your clipboard!